Selina Chen-Kiang, PhD | Authors

Articles

A Trial Investigating CDK4/6 Inhibitors for the Treatment of Mantle Cell Lymphoma

April 24, 2018

Selina Chen-Kiang, PhD, a professor of pathology and immunology at Weill Cornell Medical College, discusses the rationale of her phase I trial investigating the use of CDK4/6 inhibitors for the treatment of patients with mantle cell lymphoma.